CLINICAL_TRIALS
trial_result
· 2021-09-13
Clinical Trial Update: Safety, Tolerability and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma [Phase 2]
Summary
Phase 2 trial evaluating disulfiram with copper gluconate in recurrent glioblastoma; study completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cantex Pharmaceuticals | Conditions: Recurrent Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2021-09-13